PRKCB inhibition by enzastaurin could lead to mitotic missegregation and preferential cytotoxicity toward colorectal cancer cells with chromosomal instability; loss of PRKCA signaling is a general characteristic of colorectal tumors regardless of other underlying genetic defects, pointing to the importance of this pathway86. This evidence concerns the gene PRKCB and colorectal neoplasm.